Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Single Day And Multiple Day Ascending Dose Study To Evaluate The Safety And Pharmacokinetics Of Orally Administered ARRY-371797 In Healthy Volunteers
Conditions
Interventions
ARRY-371797, p38 inhibitor; oral
Placebo; oral
Locations
1
United States
PPD Phase I Clinic
Austin, Texas, United States
Start Date
October 31, 2008
Primary Completion Date
January 21, 2009
Completion Date
January 21, 2009
Last Updated
May 5, 2022
NCT00090662
NCT06290258
NCT06716502
NCT07310264
NCT07483606
NCT07310901
Lead Sponsor
Array Biopharma, now a wholly owned subsidiary of Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions